Institut für Gesundheitsökonomie und Management im Gesundheitswesen
(* Publikationen, die im weiteren Umfeld des MC-Health entstanden sind)
-
(2021)
Can adherence to and persistence with ILAB therapy improve the quality of life of COPD patients? Results from a German disease management program
erschienen in: Clinical Drug Investigation epub first 12 Oct -
(2021)
Concordance among Swedish, German, Danish and UK EQ-5D-3L value sets in the measurement of health-related quality of life of patients undergoing total hip replacement in Sweden
erschienen in: Journal of Clinical Medicine 10(18), 4205 -
(2021)
COVID-19 mitigation measures and nitrogen dioxide - A quasi-experimental study of air quality in Munich, Germany
erschienen in: Atmos Environ. 2021 Feb 1;246:118089 -
(2021)
Impact of clinical changes on health-related quality of life in COPD patients within one year: Real world analysis based on claims data
erschienen in: International Journal of COPD (16) 2637–51 -
(2021)
Inequality and heterogeneity in health-related quality of life: findings based on a large sample of cross-sectional EQ-5D-5L data from the Swedish general population
erschienen in: Quality of Life Research epub first 10 Oct -
(2021)
Long-term weight gain in obese COPD patients participating in a disease management program: a risk factor for reduced health-related quality of life
erschienen in: Respiratory Research 14;22(1):226 -
(2021)
The causal impact of sugar taxes on soft drink sales: evidence from France and Hungary
erschienen in: Eur J Health Econ. 2021 Apr 1. doi: 10.1007/s10198-021-01297-x. Online ahead of print.
2021
-
(2020)
COVID-19 mitigation measures and nitrogen dioxide - A quasi-experimental study of air quality in Munich, Germany
erschienen in: Atmos Environ. 2020 Nov 22: 118089. [Epub ahead of print] -
(2020)
Effect of BMI on health care expenditures stratified by COPD Gold severity grades: Results from the LQ-DMP Study
erschienen in: Respiratory Medicine Nov 02 -
(2020)
Effects of continuous enrollment in a structured Disease Management Program in patients with coronary artery disease after acute myocardial infarction on adherence to guideline recommended medication, health care expenditures, and survival
erschienen in: European Journal of Health Economics, 1 Feb https://doi.org/10.1007/s10198-020-01158-z -
(2020)
Experience-based Swedish TTO and VAS value sets for EQ-5D-5L health states
erschienen in: Pharmacoeconomics 38(8):839-56 -
(2020)
Health related quality of life associated with extreme obesity in adolescents - results from the baseline evaluation of the YES-study
erschienen in: Felix et al. Health and Quality of Life Outcomes 18:58 -
(2020)
Identification and Expert Panel Rating of Key Structural Approaches applied in Health Economic Obesity Models -
(2020)
Predictive ability of American Society of Anaesthesiologists physical status classification on health-related quality of life of patients after total hip replacement: comparison across eight EQ-5D-3L value sets
erschienen in: BMC Musculoskeletal Disorders 21:441 -
(2020)
Protocol of a population-based prospective COVID19 cohort study Munic, Germany (KoCo19)
erschienen in: BMC Public Health 20(1):1036 -
(2020)
The relationship between body mass index and health-related quality of life in COPD: real-world evidence based on claims and survey data
erschienen in: Respiratory Research 21:291
2020
-
(2019)
Assessment of excess medical costs for persons with type 2 diabetes according to age groups: an analysis of German health insurance claims data
erschienen in: Diabet Med. Dec 13. https://doi.org/10.1111/dme.14213 epub first -
(2019)
Direct and Indirect Costs of COPD Progression and its Comorbidities in a Structured Disease Management Program: REsults from the LQ-DMP Study
erschienen in: Respiratory Research 20(1):15, https://doi.org/10.1186/s12931-019-1179-7 -
(2019)
Impact of interventions to reduce overnutrition on healthcare costs related to obesity and type 2 diabetes: a systematic review
erschienen in: Nutrition Reviews, epub first 26 Nov, nuz070 -
(2019)
Is risk-stratified breast cancer screening economically efficient in Germany?
erschienen in: PLoS ONE 14:e0217213 -
(2019)
Measuring quality of life in COPD patients: Comparing disease-specific supplements to the EQ-5D-5L
erschienen in: Expert Reviews of Parmacoeconomic Outcomes, Received 14 May 2019, Accepted 28 Aug 2019, Published online: 12 Sep 2019 -
(2019)
Patient characteristics and valuation changes impact quality of life and satisfaction in total knee arthroplasty - results from a German prospective cohort study
erschienen in: Health and Quality of Life Outcomes 17:180 -
(2019)
Predicting patient-reported outcomes following hip and knee replacement surgery using supervised machine learning
erschienen in: BMC Medical Informatics and Decision Making 19:3 -
(2019)
Psychometric proberties and minimal important differences of SF-36 in Idiopathic Pulmonary Fibrosis
erschienen in: Respiratory Research 20(1):47 -
(2019)
Social media, bots and research performance
erschienen in: European Journal of Public Health 29(1):1 -
(2019)
The association of risk attitudes with the utilization of medical and preventive services, work absence and costs: results from the population-based KORA FF4 study
erschienen in: Health Economics Reviews 9(1):26 -
(2019)
Unterstanding Complexity - the Palliative Care Situation as a Complex Adaptive System
erschienen in: BMC Health Services Research. 19:157 -
(2019)
Which reimursement system fits inpatient palliative care? A qualitative interview study on clinicians ' and financing experts' experiences and views
erschienen in: Journal of Palliative Medicine 22(11): 1378-85
2019
-
(2018)
A pilot study on patient-related costs and factors associated with the cost of specialist palliative care in the hospita: First steps towards a patient classification system in Germany
erschienen in: Cost Effectiveness and Resource Allocation 16:35, https://doi.org/10.1186/s12962-018-0154-3 -
(2018)
Cost-effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMOD
erschienen in: Addiction 113(S1):65-75 -
(2018)
Cost-effectiveness of increasing the reach of smoking cessation interventions in Germany: results from the EQUIPTMOD
erschienen in: Addiction 113(S1):52-64 -
(2018)
Costs and effects of intra-operative fluorescence molecular imaging - a model-based, early assessment
erschienen in: PLoSOne 13(6):e0198137 -
(2018)
Determinants of adherence and effects on health-related quality of life after myocardial infarction: a prospective cohort stucy
erschienen in: BMC Geriatrics 18:136 -
(2018)
Development and Application of an Economic Model (EQUIPTMOD) to assess the Impact of Smoking Cessation
erschienen in: Addiction 113(S1):7-18 -
(2018)
Estimates of costs for medelling return on investment from smoking cessation interventions
erschienen in: Addiction 113(S1):32-41 -
Koller, D. ;
Mansmann, U. ;
Sundmacher, L. ;
Grill, E.
(2018)
Patient trajectories and their impact on mobility, social participation and quality of life in patients with vertigo/dizziness/balance disorders and osteoarthritis (MobilE-TRA): study protocol of an observational, practice-based cohort study
erschienen in: BMJ open 8:e022970, doi: 10.1136/bmjopen-2018-022970 -
(2018)
Personalized Mammography Screening and Screening Adherence - A Simulation and Economic Evaluation
erschienen in: Value in Health. Volume 21, Issue 7,799-808 -
(2018)
Quality of life assessment in interstitial lung diseases: a comparison of the disease-specific K-BILD with the generic EQ-5D-5L
erschienen in: Respiratory Research 19:101 -
(2018)
Redefining Diagnosis-Related Groups (DRGs) for palliative care - a cross-sectional study in two German centres
erschienen in: BMC Palliative Care 17:58 -
(2018)
Rural versus urban differences in end-of-life care for lung cancer patients in Germany
erschienen in: Supportive Care in Cancer epub first 4 Feb https://doi.org/10.1007/s00520-018-4063-y -
(2018)
Valuing health-related quality of life: Systematic variation of health perception
erschienen in: Health and Quality of Life Outcomes 16:156 -
(2018)
Zum Beitrag der gesundheitsökonomischen Forschung zur medizinischen Versorgung
erschienen in: Gesundheitsökonomie und Qualitätsmanagement 23(3): 159-165
2018
-
(2017)
Adressing the double-burden of diabetes and tuberculosis: lessons from Kyrgyzstan
erschienen in: Globalization and Health 13:16 DOI 10.1186/s12992-017-0239-3 -
(2017)
An experience-based value set for the EQ-5D-5L in Germany
erschienen in: Value in Health. Epub first, June DOI: http://dx.doi.org/10.1016/j.jval.2017.04.019 -
(2017)
An Experience-Based Value Set for the EQ-5D-5L in Germany
erschienen in: Value in Health 201, 1150-1156 -
(2017)
Costs and health-related quality of life in alpha-1-antitrypsin deficient COPD patients
erschienen in: Respiratory Research 18:60 -
(2017)
Health-related quality of life in the general German population in 2015: Results from the EQ-5D-5L
erschienen in: International Journal of Environmental Research and Public Health 14(4):426 -
(2017)
International comparison of experienced-based health values
erschienen in: Health and Quality of Life Outcomes. -
(2017)
Simulation modeling for stratified breast cancer screening - a systematic review of cost and quality of life assumptions
erschienen in: BMC Health Services Research 17:802 DOI 10.1186/s12913-017-2766-2 -
(2017)
The contribution of symptoms and comorbidities to the economic impact of COPD: An analysis of the German COSYCONET cohort
erschienen in: International Journal of COPD 4 Dec, 12:3437-48
2017
-
(2016)
Assessing quality of life in a clinical study on heart rehabilitation patients: Comparison of a value set based on experienced health with one based on given health states.
erschienen in: Health and Quality of Life Outcomes14_48 -
(2016)
Coping with the economic burden of Diabetes, TB and co-prevalence: evidence from Bishkek, Kyrgyzstan
erschienen in: BMC Health Services Research 16:118. DOI 10.1186/S12913-016-1369-7 -
(2016)
Direct and indirect costs of COPD and its comorbidities: Results from the German SOSYCONET study
erschienen in: Respir Med 2016 Feb;111:39-46 -
(2016)
EQ-5D-5L in the German general population: Comparison and evaluation of three yearly cross-section surveys
erschienen in: International Journal of Environmental Research and Public Health 13: 343 -
(2016)
Impact of chronic ischemic heart disease on the health care costs of COPD patients - an analysis of Germans claims data
erschienen in: Respiratory Medicine 118(9):112-18 -
(2016)
Lung transplantation in the spotlight: Reasons for high cost procedures
erschienen in: Journal of Heart and Lung Transplantation pii: S1053-2498(16)30165-6 -
(2016)
Measurement and valuation of health providers' time for the management of childhood pneumonia in rural Malawi: an empirical study
erschienen in: BMC Health Services Research16:314. doi 10.1186/s12913-016-1573-5 -
(2016)
Relative impact of COPD and comorbidities on generic health-related quality of life: a pooled analysis of the COSYCONET patient cohort and control subjects from the KORA and SHIP studies.
erschienen in: Resporatory Research 17:81 -
(2016)
Response to Wise et al. (Tiotropium safety in real life populations)
erschienen in: Br J Clin Pharmacol. 2016 May 20. doi: 10.1111/bcp.12970 [Epub ahead of print]
2016
-
Kirsch F
(2015)
A systematic review of quality and cost-effectiveness derived from Markov models evaluating smoking cessation interventions in patients with chronic obstructive pulmonary disease
erschienen in: Expert Rev Pharmacoecon Outcomes Res. 2015;15(2):301-16 -
Vogl M;
Leidl R;
Plötz W;
Gutacker N
(2015)
Comparison of pre- and postoperative health-related quality of life and length of stay after primary total hip replacement in matched English and German patient cohorts
erschienen in: Quality of Life Research 24(2):513-20 -
Huber M;
Wacker M;
Vogelmeier CF;
Leidl R
(2015)
Excess costs of comorbidities in chronic obstructive pulmonary disease: A systematic review
erschienen in: Plos ONE 10(4): e0123292 -
Vogl M;
Leidl R
(2015)
Informing management on the future structure of hospital care: An extrapolation of trends in demand and cost in lung diseases
erschienen in: European Journal of Health Economics, Epub first 2 June
2015
-
Fischer KE;
Leidl R
(2014)
Analysing coverage decision-making: opening Pandora's box?
erschienen in: European Journal of Health Economics 2014 15(9):899-906 -
Hatz M;
Leidl R;
Yates N;
Stollenwerk B
(2014)
A systematic review of the quality of economic models comparing thrombosis inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention
erschienen in: PharmacoEconomics 2014;32(4):377-93 -
Rogowski W;
Payne K;
Schnell-Inderst P;
Manca A;
Rochau U;
Jahn B;
Alagoz O;
Leidl R;
Siebert U
(2014)
Concepts of ‘Personalization’ in Personalized Medicine: Implications for Economic Evaluation
erschienen in: Pharmacoeconomics 2014, 33(1):49-59 -
Becker C
(2014)
Cost-of-illness studies of atrial fibrillation: methodological considerations
erschienen in: Expert Rev. Pharmacoecon. Outcomes Res. Early online, 1–24 (2014) -
Batscheider A;
Rzehak P;
Teuner C;
Wolfenstetter S;
Leidl R;
von Berg A;
Berdel D;
Hoffmann B;
Heinrich J
(2014)
Development of BMI values of German children and their healthcare costs
erschienen in: Economics and Human Biology 12 (2014) 56–66 -
Hörbrand F;
Rottenkolber D;
Fischaleck J;
Hasford J
(2014)
Erythropoietin-induced Treatment Costs in Patients Suff ering from Renal Anemia – A Comparison between Biosimilar and Originator Drugs
erschienen in: Gesundheitswesen. 2014 Nov;76(11):e79-84 -
Kohlboeck G;
Romanos M;
Teuner CM;
Holle R;
Tiesler CM;
Hoffmann B;
Schaaf B;
Lehmann I;
Herbarth O;
Koletzko S;
Bauer CP;
von Berg A;
Berdel D;
Heinrich J
(2014)
Healthcare Use and costs associated with childrens' behaviour problems - Results from the two German birth cohorts, GINI-plus and LISA-plus European
erschienen in: Child & Adolescent Psychiatry 2014, Aug;23(8):701-14 -
Mielck A;
Vogelmann M;
Leidl R
(2014)
Health-related quality of life and socioeconomic status: inequalities among adults with a chronic disease
erschienen in: Health and Quality of Life Outcome 2014, 12:58 -
Vogl M
(2014)
Hospital financing: Calculating inpatient capital costs in Germany with a comparative view on operating costs and the English costing scheme
erschienen in: Health Policy 115 (2014) 141–151 -
Rottenkolber M;
Rottenkolber D;
Fischer R;
Ibánez L;
Fortuny J;
Ballarin E;
Sabaté M;
Ferrer P;
Thürmann P;
Hasford J;
Schmiedl S
(2014)
Inhaled beta-2-agonists/muscarinic antagonists and acute myocardial infarction in COPD patients
erschienen in: Respiratory Medicine (2014) 108, 1075-1090 -
Korber K
(2014)
Potential Transferability of Economic Evaluations of Programs Encouraging Physical Activity in Children and Adolescents across Different Countries - A Systematic Review of the Literature
erschienen in: Int. J. Environ. Res. Public Health 2014, 11, 10606-10621 -
Schmiedl S;
Rottenkolber M;
Hasford J;
Rottenkolber D;
Farker K;
Drewelow B;
Hippius M;
Saljé K;
Thürmann P
(2014)
Self-Medication with Over-the-Counter and Prescribed Drugs Causing Adverse-Drug-Reaction-Related Hospital Admissions:Results of a Prospective, Long-Term Multi-Centre Study
erschienen in: Drug Saf (2014) 37:225–235 -
Witt S;
Leidl R;
Becker C;
Holle R;
Block M;
Silber S;
Brachmann J;
Stollenwerk B
(2014)
The effectiveness of cardiovascular disease prevention initiated by a German sickness fund: a time-to-event analysis of routine data
erschienen in: PLoS ONE 9(12): e114720 -
Little M;
Reitmeir P;
Peters A;
Leidl R
(2014)
The Impact of Differences between Patient and General Population EQ-5D-3L Values on the Mean Tariff Scores of Different Patient Groups
erschienen in: Value in Health 17 (2014) 364-371
2014
-
Korber K;
Teuner CM;
Lampert T;
Mielck A;
Leidl R
(2013)
Direkte Krankheitskosten von Diabetes mellitus in Deutschland: erste Abschätzung der Unterschiede zwischen Bildungsgruppen
erschienen in: Gesundheitswesen 2013; 75:812-818 -
Teuner CM;
Menn P;
Heier M;
Holle R;
John J;
Wolfenstetter B
(2013)
Impact of BMI and BMI change on future drug expenditures in adults: results from the MONICA/KORA cohort study
erschienen in: BMC Health Services Research 2013, 13:424 -
Mielck A;
Reitmeir P;
Vogelmann M;
Leidl R
(2013)
* Impact of educational level on health-related quality of life (HRQL): results from Germany based on the EuroQol (EQ-5D)
erschienen in: European Journal of Public Health 2013;23(1):45-9 -
Vogl M
(2013)
Improving patient-level costing in the English and the German ‘DRG’ system
erschienen in: Health Policy 109 (2013) 290– 300 -
Kirsch F;
Teuner CM;
Menn P;
Leidl R
(2013)
Krankheitskosten für Asthma und COPD bei Erwachsenen in der Bundesrepublik Deutschland
erschienen in: Gesundheitswesen. 2013 Dec;75(12):812-8
2013
-
Menn P;
Leidl R;
Holle R
(2012)
* A lifetime Markov model for the economic evaluation of COPD
erschienen in: Pharmacoeconomics. 2012 Sep 1;30(9):825-40 -
John J;
Wolfenstetter SB;
Wenig CM
(2012)
An economic perspective on childhood obesity: Recent findings on cost of illness and cost effectiveness of interventions
erschienen in: Nutrition 2012; 28(9): 829-839 -
Vogl M
(2012)
Assessing DRG cost accounting with respect to resource allocation and tariff calculation: the case of Germany
erschienen in: Health Economics Review 2012, 2:15 -
John J;
Teuner CM
(2012)
Combating pediatric obesity in Germany: the role of economic findings in informing policy
erschienen in: Expert Review of Pharmacoeconomics & Outcomes Research 2012, 12(6), 733-743 -
Haas L;
Stargardt T;
Schreyögg J
(2012)
Cost-effectiveness of open versus laparoscopic appendectomy: a multilevel approach with propensity score matching
erschienen in: Eur J Health Econ 2012; 13(5): 549-560 -
Heimeshoff M;
Hollmeyer H;
Schreyögg J;
Tiemann O;
Staab D
(2012)
Cost of Illness of Cystic Fibrosis in Germany: Results from a Large Cystic Fibrosis Centre
erschienen in: Pharmacoeconomics 2012; 30(9): 763-777 -
Rottenkolber D;
Hasford J;
Stausberg J
(2012)
Costs of Adverse Drug Events in German Hospitals - A Microcosting Study
erschienen in: Value in Health 2012; 15: 868-875 -
Heinrich J;
Brüske I;
Schnappinger M;
Standl M;
Flexeder C;
Thiering E;
Tischer C;
Tiesler CMT;
Kohlböck G;
Wenig CM;
Bauer CP;
Schaaf B;
von Berg A;
Berdel D;
Kraemer U;
Cramer C;
Lehmann I;
Herbarth O;
Behrendt H;
Ring J;
Kühnisch J;
Koletzko S
(2012)
Die zwei deutschen Geburtskohorten GINIplus und LISAplus
erschienen in: Bundesgesundheitsblatt 2012; 55: 864-874 -
Rottenkolber D;
Schmiedl S;
Rottenkolber M;
Thuermann P;
Hasford J;
for the Net of Regional Pharmacovigilance Centers
(2012)
Drug-Induced Blood Consumption: The Impact of Adverse Drug Reactions on Demand for Blood Components in German Departments of Internal Medicine
erschienen in: Basic & Clinical Pharmacology & Toxicology 2012; 111: 240-247 -
Batscheider A;
Zakrzewska S;
Heinrich J;
Wenig CM;
Menn P;
Bauer CP;
Hoffmann U;
Koletzko S;
Lehmann I;
Herbarth O;
von Berg A;
Berdel D;
Kraemer U;
Schaaf B;
Wichmann HE;
Leidl R
(2012)
Exposure to second-hand smoke and direct healthcare costs in children - results from two German birth cohorts, GINIplus and LISAplus
erschienen in: BMC Health Services Research 2012; 12: 344 -
Vogl M;
Wenig CM;
Leidl R;
Pokhrel S
(2012)
Smoking and health-related quality of life in English general population: implications for economic evaluations
erschienen in: BMC Public Health 2012; 12: 203 -
Leidl R;
Reitmeir P;
König HH;
Stark R
(2012)
* The performance of a value set for the EQ-5D based on experienced health states in patients with inflammatory bowel disease
erschienen in: Value in Health 2012; 15(1): 151-157 -
Italia S;
Batscheider A;
Heinrich J;
Wenig C;
Bauer CP;
Koletzko S;
Lehmann I;
Herbarth O;
von Berg A;
Berdel D;
Hoffmann B;
Schaaf B;
Wolfenstetter SB
(2012)
Utilization and costs of conventional and alternative pharmaceuticals in children: results from the German GINIplus and LISAplus birth cohort studies
erschienen in: Pharmacoepidemiology and Drug Safety 2012; 21(10): 1102-1111 -
Hunger M;
Sabariego C;
Stollenwerk B;
Cieza A;
Leidl R
(2012)
Validity, reliability and responsiveness of the EQ-5D in German stroke patients undergoing rehabilitation
erschienen in: Quality of Life Research 2012; 21(7): 1205-1216.
2012
-
Rottenkolber D;
Schmiedl S;
Rottenkolber M;
Farker K;
Saljé K;
Mueller S;
Hippius M;
Thuermann PA;
Hasford J;
for the Net of Regional Pharmacovigilance Centers
(2011)
Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations
erschienen in: Pharmacoepidemiol Drug Saf. 2011 -
Fischer KE;
Leidl R;
Rogowski WH
(2011)
* A structured tool to analyse coverage decisions: development and feasibility test in the field of cancer screening and prevention
erschienen in: Health Policy 2011 -
Leidl R;
Reitmeir P
(2011)
* A Value Set for the EQ-5D Based on Experienced Health States: Development and Testing for the German Population
erschienen in: Pharmacoeconomics. 2011 -
Wolfenstetter SB;
Wenig CM
(2011)
Costing of physical activity programmes in primary prevention: a review of the literature
erschienen in: Health Economics Review. 2011; 1:17 -
Schreyögg J;
Stargardt T;
Tiemann O
(2011)
Costs and quality of hospitals in different health care systems: a multi-level approach with propensity score matching
erschienen in: Health Econ. 2011; 20(1):85-100 -
Stollenwerk B;
Becker C;
Leidl R
(2011)
Gesundheitsökonomische Modellierung bei Diabetes mellitus
erschienen in: Der Diabetologe March 2011, Volume 7, Issue 2, pp 99-104 -
Stark RG;
John J;
Leidl R
(2011)
Health care use and costs of adverse drug events emerging from outpatient treatment in Germany: a modelling approach
erschienen in: BMC Health Serv Res. 2011; 11:9 -
Wenig CM;
Knopf H;
Menn P
(2011)
Impact of BMI on Drug Utilisation and Costs in Children and Adolescents in Germany
erschienen in: Obesity Facts Vol. 4 (Suppl.2) Okt. 2011: p.27-28. 27 -
Haas L;
Stargardt T;
Schreyögg J;
Schlösser R;
Danzer G;
Klapp BF
(2011)
* Inpatient costs and predictors of costs in the psychosomatic treatment of anorexia nervosa
erschienen in: Int J Eat Disord. 2011 -
Wenig CM;
Knopf H;
Menn P
(2011)
Juvenile obesity and its association with utilisation and costs of pharmaceuticals - results from the KiGGS study
erschienen in: BMC Health Services Research 2011; 11(1): p.340 -
Breitfelder A;
Rzehak P;
Menn P;
Wenig CM;
Wolfenstetter SB;
Leidl R;
Bauer CP;
Hoffmann U;
Koletzko S;
Lehmann I;
Herbarth O;
von Berg A;
Berdel D;
Hoffmann B;
Schaaf B;
Wichmann HE;
Heinrich J
(2011)
KN Adipositas: BMI-development patterns in children and direct healthcare costs. Results from the GINIplus and LISAplus-studies
erschienen in: Obesity Facts Vol, 4 (Suppl 2) Okt. 2011: p.16. 27 -
Steinacker JM;
Liu Y;
Muche R;
Koenig W;
Hahmann H;
Imhof A;
Kropf C;
Brandstetter S;
Schweikert B;
Leidl R;
Schiefer DH
(2011)
Long term effects of comprehensive cardiac rehabilitation in an inpatient and outpatient setting
erschienen in: Swiss Med Wkly. 2011; 140:w13141 -
Stark RG;
Schunk MV;
Meisinger C;
Rathmann W;
Leidl R;
Holle R;
for the KORA Study Group
(2011)
* Medical Care of Type 2 Diabetes in German Disease Management Programs: a Population-based Evaluation
erschienen in: Diabetes Metab Res Rev. 2011 -
Drummond M;
Jönsson B;
Rutten F;
Stargardt T
(2011)
* Reimbursement of pharmaceuticals: Reference pricing versus health technology assessment
erschienen in: Eur J Health Econ. 2011; 12(3):263-71 -
Breitfelder A;
Wenig CM;
Wolfenstetter SB;
Rzehak P;
Menn P;
John J;
Leidl R;
Bauer CP;
Koletzko S;
Röder S;
Herbarth O;
von Berg A;
Berdel D;
Kraemer U;
Schaaf B;
Wichmann HE;
Heinrich J;
the GINI-plus, LISA-plus Study Groups
(2011)
Relative weight-related costs of healthcare use by children-Results from the two German birth cohorts, GINI-plus and LISA-plus
erschienen in: Econ Hum Biol. 2011 -
Becker C;
Langer A;
Leidl R
(2011)
The quality of three decision-analytic diabetes models: a systematic health economic assessment
erschienen in: Expert Rev Pharmacoecon Outcomes Res. 2011 Dec; 11(6):751-62 -
Roll K;
Stargardt T;
Schreyögg J
(2011)
Zulassung und Erstattung von Orphan Drugs im internationalen Vergleich
erschienen in: Das Gesundheitswesen. 2011
2011
-
Blankart R;
Stargardt T;
Schreyögg J
(2010)
Access and availability of orphan drugs: an international comparison of drugs for the treatment of pulmonary arterial hypertension, chronic myeloid leukemia, and fabry disease
erschienen in: Pharmacoecon. 2010 -
Roll K;
Stargardt T;
Schreyögg J
(2010)
Authorization and Reimbursement of Orphan Drugs in an International Comparison
erschienen in: Gesundheitswesen. 2010 -
Schreyögg J;
Grabka MM
(2010)
Copayments for Ambulatory Care in Germany: A Natural Experiment using a Difference-in-Difference Approach
erschienen in: Eur J Health Econ. 2010; 11:331-41 -
Schreyögg J;
Weller J;
Stargardt T;
Herrmann K;
Bluemel C;
Dechow T;
Glatting G;
Krause BJ;
Mottaghy F;
Reske SN;
Buck AK
(2010)
Cost-effectiveness of hybrid PET/CT for staging of non-small cell lung cancer
erschienen in: J Nucl Med. 2010; 51(11):1668-75 -
Rottenkolber D
(2010)
Discrete-Choice-Experimente zur Messung der Zahlungsbereitschaft für Gesundheitsleistungen - ein anwendungsbezogener Literaturreview
erschienen in: Gesundheitsökonomie&Qualitätsmanagement. 2010. 16(4):232-244 -
Wolfenstetter SB;
Wenig CM
(2010)
Economic Evaluation and Transferability of Physical Activity Programmes in Primary Prevention: A Systematic Review
erschienen in: International Journal of Environmental Research and Public Health. 2010; 7(4):1622-1648 -
Buck AK;
Herrmann K;
Stargardt T;
Dechow T;
Krause BJ;
Schreyögg J
(2010)
* Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches
erschienen in: J Nucl Med Technol. 2010; 38(1):6-17 -
Leidl R
(2010)
* Economic modelling in public health: a tool of growing relevance
erschienen in: Eur J Public Health. 2010; 20(4):365-6 -
Haas L
(2010)
* Measurement of Patient Preferences in Ambulatory Health-Care Centres (MVZ) - A Comparison of Quality of Treatment between MVZ and Family General Practitioners
erschienen in: Das Gesundheitswesen. 2010 -
John J;
Wenig CM;
Wolfenstetter SB
(2010)
Recent economic findings on childhood obesity: cost-of-illness and cost-effectiveness of interventions
erschienen in: Curr Opin Clin Nutr Metab Care. 2010 May; 13(3):305-13 -
Wenig CM
(2010)
The impact of BMI on direct costs in Children and Adolescents: empirical findings for the German Healthcare System based on the KiGGS-study
erschienen in: Eur J Health Econ. 2012 Feb;13(1):39-50. Epub 2010 Sept 29 -
Stargardt T
(2010)
* The impact of reference pricing on switching behaviour and healthcare utilisation: The case of statins in Germany
erschienen in: Eur J Health Economics. 2010; 11(3):267-77 -
Stark R;
Reitmeir P;
Leidl R;
König HH
(2010)
* Validity, Reliability, and Responsiveness of the EQ-5D in Inflammatory Bowel Disease in Germany
erschienen in: Inflammatory Bowel Disease. 2010; 16(1):42-51 -
Wenig CM;
Breitfelder B;
Schaffrath-Rosario A
(2010)
Zusammenhang zwischen BMI und Kosten der ambulanten Versorgung bei Kindern und Jugendlichen in Deutschland - Ergebnisse aus der KiGGS-Studie
erschienen in: Obesity Facts Vol. 3 (Suppl. 1) Okt. 2010: p.12
2010
-
Schreyögg J;
Bäumler M;
Busse R
(2009)
Balancing adoption and affordability of medical devices in Europe
erschienen in: Health Policy. 2009; 92(2-3):218-24 -
Wenig CM;
Schmidt CO;
Kohlmann T;
Schweikert B
(2009)
Costs of back pain in Germany
erschienen in: Eur J Pain. 2009; 13: 280-286 -
Porzsolt F;
Schreyögg J
(2009)
* Die wissenschaftliche Evidenz und der Preis für Innovationen im Gesundheitssystem
erschienen in: Medizinische Klinik. 2009; 104(8):622-630 -
Tiemann O;
Schreyögg J
(2009)
Effects of ownership on hospital efficiency in Germany
erschienen in: Business Research Vol.2. 2009 -
Tiemann O;
Schreyögg J
(2009)
Effects of ownership on hospital efficiency in Germany
erschienen in: Business Research. 2009; 2(2):115-45 -
Mielck A;
Vogelmann M;
Schweikert B;
Leidl R
(2009)
* Gesundheitszustand bei Erwachsenen in Deutschland: Ergebnisse einer repräsentativen Befragung mit dem EuroQol 5D (EQ-5D)
erschienen in: Das Gesundheitswesen. 2009; 1-11 -
Schweikert B;
Hahmann H;
Steinacker JM;
Imhof A;
Muche R;
König W;
Liu Y;
Leidl R
(2009)
* Intervention study shows outpatient cardiac rehablitation to be economically at least as attractive as inpatient rehabilitation
erschienen in: Clin Res Cardiol. 2009; 98(12):787-795 -
Schmidt CO;
Schweikert B;
Wenig CM;
Schmidt U;
Gockel U;
Freynhagen R;
Tölle T;
Baron R;
Kohlmann T
(2009)
Modelling the prevalence and cost of back pain with neuropathic components in the general polulation
erschienen in: Eur J Pain. 2009 Nov; 13(10): 1030-5 -
Leidl R
(2009)
* Preferences, quality of life and public health
erschienen in: Editorial Eur J Public Health. 2009; 19(3):228-229 -
Stark R;
Schunk M;
Leidl R;
Meisinger C;
Holle R
(2009)
* Prozeßevaluation von Disease Management Programmen bei Typ 2 Diabetes auf Basis einer bevölkerungsrepräsentativen Studie in der Region Augsburg (KORA)
erschienen in: Betriebswirtschaftliche Forschung und Praxis. 2009; 61(3):283-301 -
Riepe M;
Mittendorf T;
Förstl H;
Frölich L;
Haupt M;
Leidl R;
Vauth C;
Graf von der Schulenburg JM
(2009)
* Quality of Life as an outcome in Alzheimer's disease and other dementias - obstacles and goals
erschienen in: BMC Neurology. 2009; 9:47
2009
-
Rottenkolber D;
Rottenkolber M;
Schmiedl S;
Szymanski J;
Hasford J
(2008)
Adverse drug reactions in Germany: Cost analysis of internal medicine hospitalizations
erschienen in: Value in Health November 2008 - Vol. 11 Issue 6: A364-5 -
Leidl R
(2008)
* A model to decompose the performance of supplementary primate health insurance markets
erschienen in: Int J Health Care Finance Econ. 2008; 8(3):193-208 -
Rottenkolber D;
Schmiedl S;
Rottenkolber M;
Hasford J
(2008)
Assessment of Blood Products Demand in the Treatment of Adverse Drug Reactions in German Hospitals
erschienen in: Transfus Med Hemother 2008; 35 (Suppl. 1):95 -
Kreck S;
Klaus J;
Leidl R;
Tirpitz C;
von Konnopka A;
Matschinger H;
König HH
(2008)
* Cost effectiveness of ibandronate for the prevention of fractures in inflammatory bowel disease-related osteoporosis: cost-utility analysis using a markov model
erschienen in: Pharmacoeconomics. 2008; 26(4):311-328 -
Schweikert B;
Hahmann HW;
Leidl R
(2008)
* Development and first assessment of a questionnaire for health care utilization and costs for cardiac patients
erschienen in: BMC Health Services Research. 2008; 8:187, 1-11 -
Graf von der Schulenburg JM;
Greiner W;
Jost F;
Klusen N;
Kubin M;
Leidl R;
Mittendorf T;
Rebscher H;
Schoeffski O;
Vauth C;
Volmer T;
Wahler S;
Wasem J;
Weber C;
and the Hanover Consensus Group
(2008)
* German recommendations on health economic evaluation – Third and updated version of the Hanover Consensus
erschienen in: Value in Health. 2008; 11(4):539-544 -
Kuhn KA;
Knoll A;
Mewes HW;
Schwaiger M;
Bode A;
Broy M;
Daniel H;
Feussner H;
Gradinger R;
Hauner H;
Höfler H;
Holzmann B;
Horsch A;
Kemper A;
Krcmar H;
Kochs EF;
Lange R;
Leidl R;
Mansmann U;
Mayr EW;
Meitinger T;
Molls M;
Navab N;
Nüsslin F;
Peschel C;
Reiser M;
Ring J;
Rummeny EJ;
Schlichter J;
Schmid R;
Wichmann E;
Ziegler S
(2008)
* Informatics and Medicine: From Molecules to Populations
erschienen in: Methods Inf Med. 2008; 47(4):283-295 -
Wenig C;
Schmidt CO;
Schmidt U;
Gockel U;
Tölle T;
Baron R;
Freynhagen R;
Kohlmann T
(2008)
Modellierung der Prävalenz und Kosten neuropathischer Rückenschmerzen
erschienen in: Der Schmerz 22 (Suppl. 2): 164. Deutscher Schmerzkongress Berlin, 08. - 11. Oktober 2008 -
Leidl R
(2008)
* Orientierungspunkte für die Beurteilung der Wirtschaftlichkeit von Gesundheitsleistungen in Deutschland
erschienen in: ZEFQ. 2008; 102(2):110-111 -
Leidl R
(2008)
* Promoting economic value in public health
erschienen in: Editorial European Journal of Public Health. 2008; 18(3):216
2008
-
Quentin W;
Neubauer S;
Leidl R;
König HH
(2007)
* Advertising bans as a means of tobacco control policy: a systematic review of time-series analysis
erschienen in: International Journal of Public Health. 2007; 52:295-307 -
Neubauer S;
Steinle T;
Gapp O;
König HH;
Leidl R
(2007)
* Informationsbasis für die Abschätzung von gesundheitspolitischen und wirtschaftlichen Folgen von Tabakkontrollmaßnahmen in Deutschland
erschienen in: Sozialer Fortschritt. 2007; 11:271-279